Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Tréluyer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|March 25, 2026
[Long-term outcomes of preterm children]Ludovic Tréluyer
European Journal of Pediatrics|March 4, 2025
Evaluation of the safety of doxapram in premature neonates born before 28 weeks of gestationLauren Saade, Elodie Zana-Taïeb, Pierre-Henri Jarreau, et al.
The Lancet Regional Health. Europe|June 29, 2026
Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability StudyMarie-Joelle Jabagi, Marion Bertrand, Amélie Gabet, et al.
Neonatology|December 8, 2021
Bronchopulmonary Dysplasia and Risk of Developmental Delay: An EPIPAGE-2 Cohort StudyLudovic Tréluyer, Pierre-Henri Jarreau, Laetitia Marchand-Martin, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|June 26, 2023
Neurodevelopment and healthcare utilisation at age 5-6 years in bronchopulmonary dysplasia: an EPIPAGE-2 cohort studyLudovic Tréluyer, Alexandra Nuytten, Isabelle Guellec, et al.
European Journal of Pediatrics|November 29, 2024
Early respiratory features of small for gestational age very preterm childrenCamille Jung, Héloïse Torchin, Pierre-Henri Jarreau, et al.
Pediatrics|March 15, 2023
Intraventricular Hemorrhage in Very Preterm Children: Mortality and Neurodevelopment at Age 5Ludovic Tréluyer, Marie Chevallier, Pierre-Henri Jarreau, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 16, 2024
Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5-6 yearsLudovic Tréluyer, Elodie Zana-Taieb, Pierre-Henri Jarreau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|March 25, 2026
[Long-term outcomes of preterm children]Ludovic Tréluyer
European Journal of Pediatrics|March 4, 2025
Evaluation of the safety of doxapram in premature neonates born before 28 weeks of gestationLauren Saade, Elodie Zana-Taïeb, Pierre-Henri Jarreau, et al.
The Lancet Regional Health. Europe|June 29, 2026
Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability StudyMarie-Joelle Jabagi, Marion Bertrand, Amélie Gabet, et al.
Neonatology|December 8, 2021
Bronchopulmonary Dysplasia and Risk of Developmental Delay: An EPIPAGE-2 Cohort StudyLudovic Tréluyer, Pierre-Henri Jarreau, Laetitia Marchand-Martin, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|June 26, 2023
Neurodevelopment and healthcare utilisation at age 5-6 years in bronchopulmonary dysplasia: an EPIPAGE-2 cohort studyLudovic Tréluyer, Alexandra Nuytten, Isabelle Guellec, et al.
European Journal of Pediatrics|November 29, 2024
Early respiratory features of small for gestational age very preterm childrenCamille Jung, Héloïse Torchin, Pierre-Henri Jarreau, et al.
Pediatrics|March 15, 2023
Intraventricular Hemorrhage in Very Preterm Children: Mortality and Neurodevelopment at Age 5Ludovic Tréluyer, Marie Chevallier, Pierre-Henri Jarreau, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 16, 2024
Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5-6 yearsLudovic Tréluyer, Elodie Zana-Taieb, Pierre-Henri Jarreau, et al.
Pageof 1